BLU-945
Product Specifications
CAS Number
2660250-10-0
Target
EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.9916
Bioactivity
BLU-945 is a reversible, potent, highly selective, and orally available epidermal growth factor receptor tyrosine kinase inhibitor (TKIs) . BLU-945 inhibits EGFR phosphorylation in EGFR L858R/T790M/C797S and EGFR ex19del/T790M/C797S mutant cell lines. BLU-945 can be used in lung cancer research, including non-small cell lung cancer (NSCLC) .
Smiles
CO[C@@H]1CCN(C[C@@H]1F)c1nccc(Nc2cc3c(ccc(N4C[C@H](CS(C)(=O)=O)[C@H]4C)c3cn2)C(C)C)n1
Molecular Formula
C28H37FN6O3S
Molecular Weight
556.7
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-256167 5 mL
2-Isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Sign In for Pricing
View Details 
bsm-61087R-BF594-TR 20 µL
Galectin 3 Recombinant Antibody, AbBy Fluor™ 594 Conjugated
Sign In for Pricing
View Details